Who has invested in Enliven Therapeutics?

Cormorant Asset Management, Surveyor Capital, Boxer Capital, Janus Henderson Investors, Logos Capital are named among the investors backing Enliven Therapeutics.

Enliven Therapeutics Funding: $230M Raised, Growth (2024)

Enliven Therapeutics funding overview

Enliven Therapeutics is based in Boulder, Colorado. Enliven Therapeutics has raised $230M in total disclosed funding. That places its disclosed total in the $100M–$250M range. Its most recent disclosed round is a Growth announced in March 2024. The round record for Enliven Therapeutics runs through 2024; nothing later has been disclosed. Investors on record include Cormorant Asset Management, Surveyor Capital, Boxer Capital, Janus Henderson Investors, Logos Capital. 5 distinct backers are named across the disclosed rounds.

Enliven Therapeutics at a glance

Total raised: $230M
Latest round: Growth
Latest round date: March 2024
Headquarters: Boulder, Colorado
Notable investors: Cormorant Asset Management, Surveyor Capital, Boxer Capital, Janus Henderson Investors, Logos Capital

Frequently asked about Enliven Therapeutics funding

How much has Enliven Therapeutics raised?: Enliven Therapeutics has raised $230M in total disclosed funding across the rounds on record.
Who has invested in Enliven Therapeutics?: Cormorant Asset Management, Surveyor Capital, Boxer Capital, Janus Henderson Investors, Logos Capital are named among the investors backing Enliven Therapeutics.
What was the latest Enliven Therapeutics funding round?: The most recent disclosed round is a Growth, announced in March 2024.
Where is Enliven Therapeutics based?: Enliven Therapeutics is based in Boulder, Colorado.
When did Enliven Therapeutics last raise?: The last disclosed Enliven Therapeutics round closed in March 2024 at Growth.

Enliven Therapeutics totals reflect disclosed capital only — undisclosed extensions and secondaries are excluded. Use the related companies in Boulder below to benchmark round size and investor mix.

Enliven Therapeutics Funding: $230M Raised, Growth (2024)

Enliven Therapeutics funding overview

Enliven Therapeutics at a glance

Frequently asked about Enliven Therapeutics funding

Companies related to Enliven Therapeutics (34)

Browse related funding lists (8)